Drug Information

Drug General Information
Drug ID
D07GDR
Former ID
DIB011021
Drug Name
AMG 282
Drug Type
Antibody
Indication Asthma [ICD10:J45] Phase 1 [524803]
Target and Pathway
Target(s) Interleukin-33 Target Info [550251]
KEGG Pathway Cytosolic DNA-sensing pathway
Influenza A
References
Ref 524803ClinicalTrials.gov (NCT02170337) A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 282 in Healthy Subjects and Subjects With Chronic Rhinosinusitis With Nasal Polyps. U.S. National Institutes of Health.
Ref 550251Clinical pipeline report, company report or official report of Amgen.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.